Cargando…
In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening
Variability in patient response to anti-cancer drugs is currently addressed by relating genetic mutations to chemotherapy through precision medicine. However, practical benefits of precision medicine to therapy design are less clear. Even after identification of mutations, oncologists are often left...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811529/ https://www.ncbi.nlm.nih.gov/pubmed/29440675 http://dx.doi.org/10.1038/s41598-018-21200-8 |